CVS Health posts Q2 net income of $2.98B, teams up with Lilly on weight-loss drugs
CVS CVS Health Corp
$104.42 -0.90%
차트·분석 보기 → - 1CVS Health (CVS) reported Q2 net income of $2.98 billion ($2.31 per share) and raised its full-year guidance significantly
- 2Adjusted EPS of $2.58 topped estimates of $1.85, while revenue rose about 7% to $106.1 billion
- 3In a partnership with Eli Lilly (LLY), CVS will display Zepbound and Foundayo pricing on its app and offer same-day pickup starting in early Q4 2026
This 3-line summary is compiled from the report below.
The Wall Street Journal +4 View original ↗🎯 오늘의 AI 픽 5종목, 무료로 전부 공개합니다
숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다